Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...

With the rapid success of OpenAI's ChatGPT and other emerging types of AI solutions in the last several years, organizations have been scrambling to adopt artificial intelligence by 'any means ...

Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without ...